{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:15:21Z","timestamp":1792815321214,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202852"],"award-info":[{"award-number":["82202852"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272762"],"award-info":[{"award-number":["82272762"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFA0914902"],"award-info":[{"award-number":["2023YFA0914902"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["202504841006"],"award-info":[{"award-number":["202504841006"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["Z240016"],"award-info":[{"award-number":["Z240016"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.canlet.2026.218557","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:06:12Z","timestamp":1777590372000},"page":"218557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The BTN3A3-TOMM22 axis preserves mitochondrial homeostasis to facilitate HCC stemness and drug resistance"],"prefix":"10.1016","volume":"655","author":[{"given":"Xiaofeng","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanglin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimeng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0726-0545","authenticated-orcid":false,"given":"Songhao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanhao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218557_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218557_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12951-025-03992-w","article-title":"Sorafenib nanomedicine in HCC: nano-bio interactions and combination therapies","volume":"24","author":"Lu","year":"2026","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.canlet.2026.218557_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217472","article-title":"Drug resistance in TKI therapy for hepatocellular carcinoma: mechanisms and strategies","volume":"613","author":"Jiang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218557_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101084","article-title":"Potential targets and therapeutics for cancer stem cell-based therapy against drug resistance in hepatocellular carcinoma","volume":"74","author":"Zhao","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2026.218557_bib5","article-title":"The current status of tumor microenvironment and cancer stem cells in sorafenib resistance of hepatocellular carcinoma","volume":"13","author":"Chen","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218557_bib6","article-title":"Diaryl pyrimidine guanidine suppresses hepatocellular carcinoma cell stemness by targeting beta-catenin signaling","volume":"15","author":"Chen","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218557_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021417","article-title":"Cellular and molecular biology of cancer stem cells of hepatocellular carcinoma","volume":"24","author":"Jeng","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218557_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12015-024-10797-1","article-title":"Mitochondria's role in the maintenance of cancer stem cells in hepatocellular carcinoma","volume":"21","author":"Elhinnawi","year":"2025","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.canlet.2026.218557_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13046-023-02931-7","article-title":"Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy","volume":"43","author":"Alcala","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218557_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167164","article-title":"Metabolic adaptations in cancer stem cells: a key to therapy resistance","volume":"1870","author":"Masoudi","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.canlet.2026.218557_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2025.102045","article-title":"Exploring the microRNA-mitochondrial nexus in hepatocellular carcinoma","volume":"84","author":"Akki","year":"2025","journal-title":"Mitochondrion"},{"key":"10.1016\/j.canlet.2026.218557_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216118","article-title":"Enhanced E6AP-mediated ubiquitination of ENO1 via LINC00663 contributes to radiosensitivity of breast cancer by regulating mitochondrial homeostasis","volume":"560","author":"Ma","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218557_bib13","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1111\/bph.15401","article-title":"Dysregulation of mitophagy and mitochondrial homeostasis in cancer stem cells: novel mechanism for anti-cancer stem cell-targeted cancer therapy","volume":"179","author":"Praharaj","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218557_bib14","doi-asserted-by":"crossref","first-page":"48988","DOI":"10.1021\/acsomega.3c08819","article-title":"Ellagic acid induces DNA damage and apoptosis in cancer stem-like cells and overcomes Cisplatin resistance","volume":"9","author":"Mandal","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.canlet.2026.218557_bib15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11033-025-10748-0","article-title":"Cancer stem cells: Mitochondria signalling pathway and strategies for therapeutic interventions","volume":"52","author":"Tan","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.canlet.2026.218557_bib16","article-title":"BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1\/2 phosphorylation","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218557_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113424","article-title":"BTN3A: a promising immune checkpoint for cancer prognosis and treatment","volume":"23","author":"Kone","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218557_bib18","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.7150\/jca.57831","article-title":"Prognostic and therapeutic significance of BTN3A proteins in tumors","volume":"12","author":"Chen","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2026.218557_bib19","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2026.218557_bib20","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.canlet.2026.218557_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41422-019-0155-6","article-title":"LSECtin on tumor-associated macrophages enhances breast cancer stemness via interaction with its receptor BTN3A3","volume":"29","author":"Liu","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218557_bib22","first-page":"308","article-title":"DGKH-mediated phosphatidic acid oncometabolism as a driver of self-renewal and therapy resistance in HCC","volume":"82","author":"Loh","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218557_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167317","article-title":"Permeabilization of the outer mitochondrial membrane: mechanisms and consequences","volume":"1870","author":"Yapryntseva","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.canlet.2026.218557_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262210977","article-title":"Targeting TOMM40 and TOMM22 to rescue Statin-Impaired mitochondrial function, dynamics, and Mitophagy in skeletal myotubes","volume":"26","author":"Yang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218557_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4508762","article-title":"Impaired mitochondrial fusion and oxidative phosphorylation triggered by high glucose is mediated by Tom22 in endothelial cells","volume":"2019","author":"Zeng","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.canlet.2026.218557_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgaf358","article-title":"Butyrophilin 3A\/2A1-independent activation of human Vgamma9Vdelta2 gammadelta T cells by bacteria","volume":"4","author":"Gombert","year":"2025","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.canlet.2026.218557_bib27","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1158\/2326-6066.CIR-24-1285","article-title":"Vgamma9Vdelta2 T cells Express an Antitumor profile associated with Anti-PD-(L)1 responses and activation defects restored by Anti-BTN3A in triple-negative breast cancer","volume":"13","author":"Fattori","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2026.218557_bib28","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/infdis\/jiae169","article-title":"Vgamma9Vdelta2 T-cells are potent inhibitors of SARS-CoV-2 replication and represent effector phenotypes in patients with COVID-19","volume":"229","author":"Gay","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2026.218557_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70541","article-title":"Tumor cell plasticity in cancer: signaling pathways and pharmaceutical interventions","volume":"6","author":"Sun","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.canlet.2026.218557_bib30","doi-asserted-by":"crossref","DOI":"10.5306\/wjco.v16.i8.106838","article-title":"Cell reprogramming in cancer: interplay of genetic, epigenetic mechanisms, and the tumor microenvironment in carcinogenesis and metastasis","volume":"16","author":"Shenoy","year":"2025","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218557_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110914","article-title":"BTN3A3 inhibits clear cell renal cell carcinoma progression by regulating the ROS\/MAPK pathway via interacting with RPS3A","volume":"112","author":"Li","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.canlet.2026.218557_bib32","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.4049\/jimmunol.1401064","article-title":"Activation of human gammadelta T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin","volume":"194","author":"Rhodes","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2026.218557_bib33","article-title":"Unraveling the role of mitochondrial dynamics in cancer stem cells: molecular basis and therapeutic implications","volume":"1880","author":"Giannitti","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2026.218557_bib34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12967-024-05404-3","article-title":"Mitochondrial GCN5L1 acts as a novel regulator for iron homeostasis to promote sorafenib sensitivity in hepatocellular carcinoma","volume":"22","author":"Hu","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218557_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.660005","article-title":"Oxidative stress activated by sorafenib alters the temozolomide sensitivity of human glioma cells through autophagy and JAK2\/STAT3-AIF axis","volume":"9","author":"Wei","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2026.218557_bib36","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1002\/ptr.7948","article-title":"Escin enhanced the efficacy of sorafenib by autophagy-mediated apoptosis in lung cancer cells","volume":"37","author":"Hussain","year":"2023","journal-title":"Phytother Res."},{"key":"10.1016\/j.canlet.2026.218557_bib37","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.tcb.2023.03.009","article-title":"Mitochondria in cancer stem cells: achilles heel or hard armor","volume":"33","author":"Zheng","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.canlet.2026.218557_bib38","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-023-06261-8","article-title":"BTN3A3 evasion promotes the zoonotic potential of influenza A viruses","volume":"619","author":"Pinto","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218557_bib39","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.4251\/wjgo.v16.i11.4506","article-title":"Pathologic complete response to conversion therapy in hepatocellular carcinoma using patient-derived organoids: a case report","volume":"16","author":"He","year":"2024","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.canlet.2026.218557_bib40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00535-025-02308-x","article-title":"Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in unresectable hepatocellular carcinoma","volume":"61","author":"Maesaka","year":"2026","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.canlet.2026.218557_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1472870","article-title":"Efficacy and safety of atezolizumab-bevacizumab vs pembrolizumab-lenvatinib in unresectable hepatocellular carcinoma: a retrospective, cohort study","volume":"15","author":"Hu","year":"2024","journal-title":"Front. Immunol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:48:26Z","timestamp":1783194506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526003204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":41,"alternative-id":["S0304383526003204"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218557","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The BTN3A3-TOMM22 axis preserves mitochondrial homeostasis to facilitate HCC stemness and drug resistance","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218557"}}